{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-N-10606", "FDA", "Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments\u2014New Drug Application (NDA) 219694 for atropine sulfate ophthalmic solution, 0.01%", "Nonrulemaking", "2026-10-14T16:39:30Z", "0b000064b9515dd8", null, null, null, null, null, null, null, null, null, null, "list_pull"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id", "rin", "dkabstract", "category", "subtype", "keywords", "program", "short_title", "effective_date", "organization", "attrs_raw", "attr_source"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-N-10606"], "units": {}, "query_ms": 0.23776991292834282, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}